Evogene Ltd (EVGN) Stock Analysis
Verdict: AVOID
Significant insider buying and a 40% monthly rally signal a speculative floor, but chronic cash burn and negative equity demand caution.
Investment score: 38/100
Analysis as of
Is Evogene Ltd stock worth reviewing? AI model thesis
Evogene is a distressed AI-biology play with deteriorating balance sheet health and extreme earnings volatility. Despite a recent insider vote of confidence, the massive cash burn and shareholder dilution (shares outstanding grew from 4.1M to 7.8M in 4 years) make it a high-probability loser for non-specialists.
7-factor investment score
- Valuation: 30/100 (weight 20%)
- Financial Health: 25/100 (weight 15%)
- Technical Momentum: 55/100 (weight 15%)
- Earnings Quality: 20/100 (weight 15%)
- Insider Sentiment: 90/100 (weight 10%)
- Analyst Consensus: 75/100 (weight 10%)
- Risk-Adjusted Return: 25/100 (weight 15%)
Evogene Ltd opportunities and risks
What speaks for EVGN
- Massive Insider Buy at $0.50
What speaks against EVGN
- Negative Shareholder Equity
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| EVGN | n/a | 2.9x | 0.1x | 30.9% | -639.4% | -228.2% |
| PLUR | n/a | 16.0x | n/a | 19.0% | -2424.7% | -125.6% |
| NRSN | n/a | 0.0x | n/a | 0.0% | 0.0% | -23.0% |
| CMMB | n/a | 0.0x | n/a | 0.0% | 0.0% | -95.4% |
| QNRX | n/a | 0.0x | n/a | 0.0% | 0.0% | -155.2% |
| Peer median | n/a | 0.0x | n/a | 0.0% | 0.0% | -110.5% |
Frequently asked questions about Evogene Ltd (EVGN)
Is EVGN stock a good investment?
The cached TradeMates AI model rates Evogene Ltd as AVOID with an investment score of 38/100. Evogene is a distressed AI-biology play with deteriorating balance sheet health and extreme earnings volatility. Despite a recent insider vote of confidence, the massive cash burn and shareholder dilution (shares outstanding grew from 4.1M to 7.8M in 4 years) make it a high-probability loser for non-specialists. This is algorithmic model output, not personal investment advice.
Is EVGN stock a buy?
The TradeMates model verdict for EVGN is AVOID with an investment score of 38/100. Treat this as a model signal to review, not a personal buy recommendation.